Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer

被引:11
|
作者
Yu, Chunying [1 ]
Dou, Ting [1 ]
Liu, Yun [1 ]
Liu, Ruirong [1 ]
机构
[1] Third Peoples Hosp Qingdao, Dept Ultrason Med, 29 Yongping Rd, Qingdao 266041, Shandong, Peoples R China
关键词
ovarian cancer; color doppler ultrasound; transvaginal; tumor markers; serology; combined examination; DOPPLER SONOGRAPHY; OSTEOPONTIN; STAGE; DISCRIMINATION; ULTRASOUND; CA125;
D O I
10.3892/ol.2020.11705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical application value was investigated of transvaginal color Doppler ultrasound (TV-CDS) combined with serum tumor markers carbohydrate antigen 125 (CA125), vascular endothelial growth factor (VEGF) and osteopontin (OPN) in the diagnosis of ovarian cancer (OC). One hundred and six patients with OC [malignant tumor group (MTG)] and fifty patients with benign ovarian diseases [benign control group (BCG)] were selected. Both groups of patients underwent TV-CDS examination. The lesion morphology and internal structure were observed, and the tumor blood flow signal, resistance index (RI) and pulsability index (PI) under ultrasound were determined. Serum CA125 was detected by electrochemiluminescence, and VEGF and OPN levels were detected by enzyme-linked immunosorbent assay. The incidence of irregular lesion morphology, unclear boundary, uneven internal echo, microcalcification and side-acoustic images in OC group (OCG) was significantly higher than that in BCG (P<0.01). As for blood flow grading, most patients in the MTG were in grade II and III, while most patients in the BCG were in grade 0. Compared with BCG, the flow RI and PI in the OCG were significantly reduced (P<0.01). The levels of serum CA125, VEGF and OPN in OCG were significantly higher than those in BCG. The expression levels of serum CA125, VEGF and OPN in OC patients with clinical high stage (stage III and IV), poorly differentiated, ascites, recurrence and metastasis were significantly higher than those in patients with clinical low stage (stage I and II), well differentiated, no ascites and no recurrence and metastasis (P<0.05). With the disappearance of the tumor or the decrease of tumor load, the serum marker levels after treatment were significantly lower than that before treatment (P<0.05). The sensitivity and accuracy of the combined examination in the diagnosis of OC were obviously improved compared with the single and partial combined examinations (P<0.05). In conclusion, combined examination can significantly improve the sensitivity and accuracy of OC, which is conducive to early diagnosis and clinical intervention of OC.
引用
收藏
页码:2028 / 2034
页数:7
相关论文
共 50 条
  • [41] Prognostic value of preoperative serum tumor markers in gastric cancer
    Huang, Ze-Bo
    Zhou, Xin
    Xu, Jun
    Du, Yi-Ping
    Zhu, Wei
    Wang, Jian
    Shu, Yong-Qian
    Liu, Ping
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (02): : 170 - 176
  • [42] Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer
    Yan, Tianqing
    Wang, Haozhe
    Ma, Xiaolu
    Cao, Jiazhen
    Tong, Ying
    Guo, Lin
    Lu, Renquan
    BIOMARKERS IN MEDICINE, 2023, 17 (06) : 325 - 336
  • [43] Diagnostic Value of Serum Markers Combined with TVCDS in Ovarian Cancer Patients Treated with Bushen Yiqi Quyu Prescription
    Qin, Wei
    Jiang, Fengmin
    Zhang, Tao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [44] Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer
    Wang, Yun-Feng
    Feng, Fei-Ling
    Zhao, Xu-Hong
    Ye, Zhen-Xiong
    Zeng, He-Ping
    Li, Zhen
    Jiang, Xiao-Qing
    Peng, Zhi-Hai
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 4085 - 4092
  • [45] Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer
    Yun-Feng Wang
    Fei-Ling Feng
    Xu-Hong Zhao
    Zhen-Xiong Ye
    He-Ping Zeng
    Zhen Li
    Xiao-Qing Jiang
    Zhi-Hai Peng
    World Journal of Gastroenterology, 2014, 20 (14) : 4085 - 4092
  • [46] VALUE OF ULTRASONOGRAPHIC EXAMINATION COMBINED WITH MEASUREMENT OF SERUM TUMOR-MARKERS IN THE DIAGNOSIS OF PANCREATIC-CANCER OF LESS THAN 3 CM IN DIAMETER
    IISHI, H
    YAMAMURA, H
    TATSUTA, M
    OKUDA, S
    KITAMURA, T
    CANCER, 1986, 57 (10) : 1947 - 1951
  • [47] Tumor markers serum levels for early diagnosis of prostate cancer
    Topolcan, O.
    Fuchsova, R.
    Klecka, J.
    Hora, M.
    Vrzalova, J.
    TUMOR BIOLOGY, 2012, 33 : 47 - 48
  • [48] Serum tumor markers and molecular biological diagnosis in pancreatic cancer
    Sawabu, N
    Watanabe, H
    Yamaguchi, Y
    Ohtsubo, K
    Motoo, Y
    PANCREAS, 2004, 28 (03) : 263 - 267
  • [49] Tumor Markers in ovarian cancer
    Duffy, Michael J.
    Esteva, Francisco J.
    Harbeck, Nadia
    Hayes, Daniel F.
    Molina, Rafael
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2014, 48 (01): : 88 - 106
  • [50] Tumor markers in ovarian cancer
    Raspollini, M. R.
    Taddei, G. L.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2007, 29 (8-9): : 295 - 302